TCG Labs Soleil has secured another $400 million to expand its global R&D footprint and help build out its growing portfolio ...

Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Chief executive Thomas Schinecker believes the price of drugs in the USA could be lowered considerably if this model were ...

It has been a stellar week for Abivax, a French biotech developing therapeutics that harness the body’s natural regulatory ...

French drugmaker Ipsen announced that the European Commission (EC) has approved Cabometyx (cabozantinib) for adult patients ...

The Trump administration has asked the US Supreme Court to allow the National Institutes of Health (NIH) to resume canceling ...

Swiss pharma major Novartis (NOVN: VX) has entered into an exclusive option and license deal with Matchpoint Therapeutics to ...

In an import contrast to events in the USA, UK pharma major GSK late Thursday announced the approval of Blenrep (belantamab ...

Following the positive opinion by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on ...

California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

Privately-held Danish dermatology specialist LEO Pharma today revealed that the US Food and Drug Administration (FDA) has ...

The number of new pharmaceutical companies being set up in Russia is steadily declining due to sanctions and the ever-growing ...